Replies to post #221327 on Biotech Values

[DewDiligence]

I listened to MNTA’s R&D webcast (~3 hrs) even though I no longer have a position.

It’s fair to say that this is a brand new company, for all practical purposes. The upside is impressive if the technology works the way MNTA thinks it will, but it will likely take investors a few years to know whether it does.